Cargando…

A Study of DNA Methylation of Bladder Cancer Biomarkers in the Urine of Patients with Neurogenic Lower Urinary Tract Dysfunction

SIMPLE SUMMARY: As patients with neurogenic bladders are at higher risk for advanced-stage bladder cancer, it is important to develop non-invasive screening methods for bladder cancer other than cystoscopy in this patient population. We conducted a study to explore changes in five bladder cancer-ass...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koukourikis, Periklis, Papaioannou, Maria, Georgopoulos, Petros, Apostolidis, Ioannis, Pervana, Stavroula, Apostolidis, Apostolos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452268/ https://www.ncbi.nlm.nih.gov/pubmed/37627010 http://dx.doi.org/10.3390/biology12081126

Ejemplares similares

Urine Biomarkers in the Management of Adult Neurogenic Lower Urinary Tract Dysfunction: A Systematic Review
por: Koukourikis, Periklis, et al.
Publicado: (2023)

Role of Pelvic Ischemia in Human Lower Urinary Tract Symptoms and Sexual Function Among Patients With Common Iliac Artery Obstruction Undergoing Revascularization Surgery
por: Papaefstathiou, Efstathios, et al.
Publicado: (2023)

Clinical usefulness of urine cytology in the detection of bladder tumors in patients with neurogenic lower urinary tract dysfunction
por: Pannek, Jürgen, et al.
Publicado: (2017)

The Effect of Low-Intensity Extracorporeal Shockwave Treatment on the Urinary Bladder in an Experimental Diabetic Rat Model
por: Dimitriadis, Fotios, et al.
Publicado: (2021)

Effect of Bladder Injection of OnabotulinumtoxinA on the Central Expression of Genes Associated with the Control of the Lower Urinary Tract: A Study in Normal Rats
por: Markopoulou, Soultana, et al.
Publicado: (2022)

Optimal bladder diary duration for patients with suprapontine neurogenic lower urinary tract dysfunction
por: Konstantinidis, Charalampos, et al.
Publicado: (2016)

The effect of pharmacotherapy on prostate volume, prostate perfusion and prostate-specific antigen (prostate morphometric parameters) in patients with lower urinary tract symptoms and benign prostatic obstruction. A systematic review and meta-analysis
por: Sakalis, Vasileios, et al.
Publicado: (2021)

Urinary tract infection in the neurogenic bladder
por: Vigil, Humberto R., et al.
Publicado: (2016)

Detrusor Overactivity May Be a Prognostic Factor for Better Response to Combination Therapy Over Monotherapy in Male Patients With Benign Prostatic Enlargement and Storage Lower Urinary Tract Symptoms
por: Sakalis, Vasileios, et al.
Publicado: (2021)

Neurogenic Lower Urinary Tract Dysfunction in Asymptomatic Patients with Multiple Sclerosis
por: Jaekel, Anke K., et al.
Publicado: (2022)

Editorial Comment: Sacral neuromodulation for neurogenic Lower Urinary Tract Dysfunction
por: Averbeck, Marcio Augusto
Publicado: (2023)

Molecular Characterization of Non-Neurogenic and Neurogenic Lower Urinary Tract Dysfunction (LUTD) in SCI-Induced and Partial Bladder Outlet Obstruction Mouse Models
por: von Siebenthal, Michelle, et al.
Publicado: (2023)

New Frontiers of Basic Science Research in Neurogenic Lower Urinary Tract Dysfunction
por: Miyazato, Minoru, et al.
Publicado: (2017)

Is there a role for sacral neuromodulation in patients with neurogenic lower urinary tract dysfunction?
por: Averbeck, Marcio Augusto, et al.
Publicado: (2020)

Clinical Predictors of Neurogenic Lower Urinary Tract Dysfunction in Persons with Multiple Sclerosis
por: Beck, Janina, et al.
Publicado: (2022)

Posing as Ascites: A Case Report on Neurogenic Lower Urinary Tract Dysfunction
por: Sousa, Luís Carlos, et al.
Publicado: (2023)

The concerns of mechanical upper urinary tract obstruction in neurogenic lower urinary tract dysfunction: Beyond augmentation cystoplasty
por: Zhou, Zhonghan, et al.
Publicado: (2023)

Association Between the Neurogenic Bladder Symptom Score and Urodynamic Examination in Multiple Sclerosis Patients With Lower Urinary Tract Dysfunction
por: Fragalà, Eugenia, et al.
Publicado: (2015)

Defining Voiding Dysfunction in Women: Bladder Outflow Obstruction Versus Detrusor Underactivity
por: Mytilekas, Konstantinos-Vaios, et al.
Publicado: (2021)

Contractile and Structural Properties of Detrusor from Children with Neurogenic Lower Urinary Tract Dysfunction
por: Johal, Navroop, et al.
Publicado: (2021)

Neurogenic Lower Urinary Tract Dysfunction in Spinal Dysraphism: Morphological and Molecular Evidence in Children
por: Planta, Dafni, et al.
Publicado: (2023)

Molecular Mechanisms of Neurogenic Lower Urinary Tract Dysfunction after Spinal Cord Injury
por: Shimizu, Nobutaka, et al.
Publicado: (2023)

Optogenetic Modulation of Urinary Bladder Contraction for Lower Urinary Tract Dysfunction
por: Park, Jae Hong, et al.
Publicado: (2017)

Long-term outcomes of urinary tract reconstruction in patients with neurogenic urinary tract dysfunction
por: Johnson, E. U., et al.
Publicado: (2013)

Onabotulinum Toxin A Intradetrusor Injections in Children with Neurogenic Lower Urinary Tract Dysfunction: Long-Term Histological Effects on the Bladder Wall
por: Pellegrino, Chiara, et al.
Publicado: (2023)

Do We Need Surveillance Urethro-Cystoscopy in Patients with Neurogenic Lower Urinary Tract Dysfunction?
por: Sammer, Ulla, et al.
Publicado: (2015)

Frontiers in the Clinical Applications of Botulinum Toxin A as Treatment for Neurogenic Lower Urinary Tract Dysfunction
por: Jiang, Yuan-Hong, et al.
Publicado: (2020)

Adult Neurogenic Lower Urinary Tract Dysfunction and Intermittent Catheterisation in a Community Setting: Risk Factors Model for Urinary Tract Infections
por: Kennelly, Michael, et al.
Publicado: (2019)

Management of urinary tract infections in patients with neurogenic bladder: challenges and solutions
por: Pannek, Jürgen, et al.
Publicado: (2017)

Current Surgical Treatment for Neurogenic Lower Urinary Tract Dysfunction in Patients with Chronic Spinal Cord Injury
por: Fan, Yu-Hua, et al.
Publicado: (2023)

Relationship between urodynamic patterns and lower urinary tract symptoms in Chinese women with a non-neurogenic bladder
por: Wang, Linhui, et al.
Publicado: (2016)

Early warning model construction and validation for urinary tract infection in patients with neurogenic lower urinary tract dysfunction (NLUTD): a retrospective study
por: Zhou, Liqiong, et al.
Publicado: (2022)

Editorial Comment: Intradetrusor botulinum toxin injections (300 units) for the treatment of poorly compliant bladders in patients with adult neurogenic lower urinary tract dysfunction
por: Averbeck, Marcio Augusto
Publicado: (2021)

Pathophysiology, Clinical Importance, and Management of Neurogenic Lower Urinary Tract Dysfunction Caused by Suprasacral Spinal Cord Injury
por: Hu, H.Z., et al.
Publicado: (2016)

The Efficacy and Safety of Mirabegron for the Treatment of Neurogenic Lower Urinary Tract Dysfunction: A Systematic Review and Meta-analysis
por: Zhang, Dongxu, et al.
Publicado: (2021)

Sonographic evaluation of bladder wall thickness in women with lower urinary tract dysfunction
por: Shin, Un Ju, et al.
Publicado: (2018)

Identification of Urinary CD44 and Prosaposin as Specific Biomarkers of Urinary Tract Infections in Children With Neurogenic Bladders
por: Forster, Catherine S, et al.
Publicado: (2019)

A novel intracerebral hemorrhage-induced rat model of neurogenic voiding dysfunction: Analysis of lower urinary tract function
por: CHO, YOUNG-SAM, et al.
Publicado: (2015)

An integrative review of standardized clinical evaluation tool utilization in anticholinergic drug trials for neurogenic lower urinary tract dysfunction
por: Stothers, L, et al.
Publicado: (2016)

Spinal cord injury and neurogenic lower urinary tract dysfunction: what do we know and where are we going?
por: Dodd, William, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_16tofqag7fo2ffjg9p6qm4pc1p